Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Aug;62(8):1153-9.
doi: 10.1136/gutjnl-2012-302362. Epub 2012 May 22.

Oral contraceptives, reproductive factors and risk of inflammatory bowel disease

Hamed Khalili  1 , Leslie M Higuchi, Ashwin N Ananthakrishnan, James M Richter, Diane Feskanich, Charles S Fuchs, Andrew T Chan
Affiliations

Oral contraceptives, reproductive factors and risk of inflammatory bowel disease

Hamed Khalili et al. Gut. 2013 Aug.

Abstract

Background: Oral contraceptive use has been associated with risk of Crohn's disease (CD) and ulcerative colitis (UC).

Objective: To determine whether this association is confounded or modified by other important lifestyle and reproductive factors.

Design: A prospective cohort study was carried out of 117,375 US women enrolled since 1976 in the Nurses Health Study I (NHS I) and 115,077 women enrolled since 1989 in the Nurses' Health Study II (NHS II) with no prior history of UC or CD. These women had provided information every 2 years, on age at menarche, oral contraceptive use, parity, menopause status and other risk factors. Diagnoses of CD and UC were confirmed by review of medical records. Cox proportional hazards models were used to calculate HRs and 95% CIs.

Results: Among 232,452 women with over 5,030,196 person-years of follow-up, 315 cases of CD and 392 cases of UC were recorded through 2007 in NHS II and 2008 in NHS I. Compared with never users of oral contraceptives, the multivariate-adjusted HRs for CD were 2.82 (95% CI 1.65 to 4.82) among current users and 1.39 (95% CI 1.05 to 1.85) among past users. The association between oral contraceptives and UC differed according to smoking history (pheterogeneity=0.04). Age at menarche, age at first birth and parity were not associated with risk of UC or CD.

Conclusion: In two large prospective cohorts of US women, oral contraceptive use was associated with risk of CD. The association between oral contraceptive use and UC was limited to women with a history of smoking.

Keywords: Crohn's colitis; Crohn's disease; IBD clinical; Inflammatory bowel disease; Nurses' Health Study; adenocarcinoma; adenoma; aspirin; cancer epidemiology; cancer prevention; chemoprevention; cyclooxygenase-2; epidemiology; gastrointestinal haemorrhage; health service research; inflammation; non-steroidal anti-inflammatory drugs; oral contraceptive use; reproductive factors; ulcerative colitis.

PubMed Disclaimer

Comment in

References

    1. Anderson CA, Boucher G, Lees CW, et al. Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47. Nat Genet. 2011;43:246–52. - PMC - PubMed
    1. Franke A, McGovern DP, Barrett JC, et al. Genome-wide meta-analysis increases to 71 the number of confirmed Crohn’s disease susceptibility loci. Nat Genet. 2010;42:1118–25. - PMC - PubMed
    1. Abraham C, Cho JH. Inflammatory bowel disease. N Engl J Med. 2009;361:2066–78. - PMC - PubMed
    1. Boyko EJ, Theis MK, Vaughan TL, et al. Increased risk of inflammatory bowel disease associated with oral contraceptive use. Am J Epidemiol. 1994;140:268–78. - PubMed
    1. Calkins BM, Mendeloff AI, Garland C. Inflammatory bowel disease in oral contraceptive users. Gastroenterology. 1986;91:523–4. - PubMed

Publication types

Substances